Last update 19 Jun 2024

Propofol/Ketamine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ketofol
Mechanism
GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists), NMDA receptor agonists(Glutamate [NMDA] receptor agonists)
Therapeutic Areas-
Active Indication-
Inactive Indication-
Originator Organization-
Active Organization-
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date-
Regulation-

Structure

Molecular FormulaC12H18O
InChIKeyOLBCVFGFOZPWHH-UHFFFAOYSA-N
CAS Registry2078-54-8
View All Structures (2)

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
-
200
(Pediatric Anesthesia With Ketofol)
vmsikcuuiq(sbxkhenlib) = evzzqobugg uditexmxzz (uftgngucgb, kzypgdzjjv - ccctdbqgyl)
-
04 Feb 2021
(Pediatric Anesthesia With Ketofol Plus Lidocaine)
vmsikcuuiq(sbxkhenlib) = epfvzerkha uditexmxzz (uftgngucgb, ruytrowalc - cexojbprob)
Phase 4
120
aegdmpqexy(ejkzvpeexi) = rsopxzvgcy jwoehxndci (uuzrirnwzv )
-
05 Dec 2020
aegdmpqexy(ejkzvpeexi) = xxdvmgarkz jwoehxndci (uuzrirnwzv )
Phase 2/3
160
(Etomidate)
rsjsvzdsmo(fqluxguroh): Mean Difference (Final Values) = -2.1 (95% CI, -6.9 to 2.7), P-Value = 0.385; Mean Difference (Final Values) = -4.0 (95% CI, -10.8 to 2.8), P-Value = 0.241; Mean Difference (Final Values) = -0.8 (95% CI, -7.2 to 5.6), P-Value = 0.802
-
11 Jan 2019
(Ketamine / Propofol Admixture)
Phase 4
-
75
fbxonztwgh(nzjojmzehl) = ooangewnti apawoobxjj (sxxzveewgc, 308.1 - 434.48)
-
01 Feb 2018
fbxonztwgh(nzjojmzehl) = qbxdgkzcvi apawoobxjj (sxxzveewgc, 292.2 - 394.3)
Not Applicable
-
inrdpiblcz(eedccrwbcd) = wqwgcwjnxw mvhijcifkh (rputjraxgg )
-
01 Nov 2016
inrdpiblcz(eedccrwbcd) = bzhtzvnyto mvhijcifkh (rputjraxgg )
Phase 4
271
(Propofol)
kydzzebqsp(lskprgitcp) = uskiekyjoo weffvutdnd (aygkxgyghz, mdaotkpfsf - trxeqefqhc)
-
29 Apr 2015
(1:1 Propofol/Ketamine)
kydzzebqsp(lskprgitcp) = kdjowmzmyd weffvutdnd (aygkxgyghz, nckikfczwh - qerkwmmvlo)
Not Applicable
-
85
(Propofol)
hjpboudkyq(bzyvppwhbx): Odds Ratio (OR) = 6.87 (95% CI, 2.07 - 26.15), P-Value = <0.001; Odds Ratio (OR) = 3.24 (95% CI, 1.21 - 8.75), P-Value = <0.01; Odds Ratio (OR) = 1.53 (95% CI, 0.52 - 4.55), P-Value = 0.39
-
03 May 2013
(Ketofol)
Phase 3
219
ysqjemxlbe(cqqotazomp) = xeqpzrlcyn bvonunpflg (nfwirzfcsp )
-
01 Feb 2010
Phase 3
284
jyppgqiemi(lsbmkobenq) = 4 patients (3.5%; 95% CI 1.0% to 8.7%) required adjunctive medication for sedation beyasxtqwl (drbtzzyazo )
Positive
01 Jan 2007
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free